Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study

by Edyta Szymanska, Maciej Dadalski, Joanna Sieczkowska-Golub, Dorota Jarzebicka, Monika Meglicka, Marcin Osiecki, Anna Wiernicka, Dariusz M. Lebensztejn, Bartosz Korczowski, Jaroslaw Kierkus
Published 2021-07-01